Skip to main content
Erschienen in: World Journal of Surgery 10/2015

01.10.2015 | Original Scientific Report

Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients

verfasst von: Benjamin Weixler, Rene Warschkow, Andreas Zettl, Hans-Martin Riehle, Ulrich Guller, Carsten T. Viehl, Markus Zuber

Erschienen in: World Journal of Surgery | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Small nodal tumor infiltrates (SNTI)—defined as isolated tumor cells and micrometastases—are associated with worse disease-free and overall survival in stage I and II colon cancer patients. Their detection, however, remains challenging. The objective of the present study was to evaluate whether there is a correlation between the location of SNTI and phagocytosed carbon dye particles in sentinel lymph nodes (SLN) of colon cancer patients.

Materials and Methods

Isosulfan blue and carbon dye were injected intraoperatively near the tumor to mark the SLN. Serial sections of SLN were stained with hematoxylin–eosin and immunohistochemistry. Intranodal distribution of phagocytosed carbon particles was compared to the presence of SNTI.

Results

Of a cohort of 159 patients, 24 patients had SNTI in their lymph nodes (LN). SNTI were found in a total of 116 LN of which 66 were SLN and 50 were non-SLN. In 59, these 116 LN with SNTI phagocytosed carbon dye were found (50.9 %). Phagocytosed carbon dye was identified significantly more often in SLN (49 of 66 SNTI positive SLN) compared to 10 of 50 SNTI positive non-SLN (p < 0.001). In 52 out of 59 LN (88.1 %), phagocytosed carbon dye was in close proximity to SNTI.

Conclusions

In the majority of patients, SNTI are located in the same SLN compartment as phagocytosed carbon dye particles. Our investigation provides evidence that the use of carbon dye facilitates SNTI detection and improves LN staging in colon cancer. Therefore, the concept of intranodal mapping—which has been previously described for melanoma—can be extended to colon cancer patients.
Literatur
1.
Zurück zum Zitat Center MM, Jemal A, Smith RA et al (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378CrossRefPubMed Center MM, Jemal A, Smith RA et al (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378CrossRefPubMed
2.
3.
Zurück zum Zitat Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244:602–610PubMedCentralPubMed Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244:602–610PubMedCentralPubMed
4.
Zurück zum Zitat Le Voyer TE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919CrossRefPubMed Le Voyer TE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919CrossRefPubMed
5.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AE (2010) American Joint Committee on Cancer-cancer staging handbook, TNM classification of malignant tumors, 7th edn. Springer, New York Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AE (2010) American Joint Committee on Cancer-cancer staging handbook, TNM classification of malignant tumors, 7th edn. Springer, New York
6.
Zurück zum Zitat Figueredo A, Coombes ME, Mukherjee S (2008) Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev CD005390 Figueredo A, Coombes ME, Mukherjee S (2008) Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev CD005390
7.
Zurück zum Zitat Sirop S, Kanaan M, Korant A et al (2011) Detection and prognostic impact of micrometastasis in colorectal cancer. J Surg Oncol 103:534–537CrossRefPubMed Sirop S, Kanaan M, Korant A et al (2011) Detection and prognostic impact of micrometastasis in colorectal cancer. J Surg Oncol 103:534–537CrossRefPubMed
8.
Zurück zum Zitat Hermanek P, Hutter RV, Sobin LH et al (1999) International Union Against Cancer. classification of isolated tumor cells and micrometastasis. Cancer 86:2668–2673CrossRefPubMed Hermanek P, Hutter RV, Sobin LH et al (1999) International Union Against Cancer. classification of isolated tumor cells and micrometastasis. Cancer 86:2668–2673CrossRefPubMed
9.
Zurück zum Zitat Leong SP, Zuber M, Ferris RL et al (2011) Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol 103:518–530CrossRefPubMed Leong SP, Zuber M, Ferris RL et al (2011) Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J Surg Oncol 103:518–530CrossRefPubMed
10.
Zurück zum Zitat Faerden AE, Sjo OH, Bukholm IR et al (2011) Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer. Dis Colon Rectum 54:200–206CrossRefPubMed Faerden AE, Sjo OH, Bukholm IR et al (2011) Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer. Dis Colon Rectum 54:200–206CrossRefPubMed
11.
Zurück zum Zitat Iddings D, Ahmad A, Elashoff D et al (2006) The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 13:1386–1392CrossRefPubMed Iddings D, Ahmad A, Elashoff D et al (2006) The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol 13:1386–1392CrossRefPubMed
12.
Zurück zum Zitat Mescoli C, Albertoni L, Pucciarelli S et al (2012) Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol 30:965–971CrossRefPubMed Mescoli C, Albertoni L, Pucciarelli S et al (2012) Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol 30:965–971CrossRefPubMed
13.
Zurück zum Zitat Saha S, Sehgal R, Patel M et al (2006) A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 191:305–310CrossRefPubMed Saha S, Sehgal R, Patel M et al (2006) A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg 191:305–310CrossRefPubMed
14.
Zurück zum Zitat van der Zaag ES, Buskens CJ, Kooij N et al (2009) Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping: a comparative study. Eur J Surg Oncol 35:1065–1070CrossRefPubMed van der Zaag ES, Buskens CJ, Kooij N et al (2009) Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping: a comparative study. Eur J Surg Oncol 35:1065–1070CrossRefPubMed
15.
Zurück zum Zitat Bilchik AJ, Saha S, Wiese D et al (2001) Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 19:1128–1136PubMed Bilchik AJ, Saha S, Wiese D et al (2001) Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol 19:1128–1136PubMed
16.
Zurück zum Zitat Stojadinovic A, Nissan A, Protic M et al (2007) Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 245:846–857PubMedCentralCrossRefPubMed Stojadinovic A, Nissan A, Protic M et al (2007) Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg 245:846–857PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Wasif N, Faries MB, Saha S et al (2010) Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial. Surgery 147:352–357CrossRefPubMed Wasif N, Faries MB, Saha S et al (2010) Predictors of occult nodal metastasis in colon cancer: results from a prospective multicenter trial. Surgery 147:352–357CrossRefPubMed
18.
Zurück zum Zitat Koyanagi K, Bilchik AJ, Saha S et al (2008) Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res 14:7391–7396PubMedCentralCrossRefPubMed Koyanagi K, Bilchik AJ, Saha S et al (2008) Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin Cancer Res 14:7391–7396PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Guller U, Zettl A, Worni M et al (2012) Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging? Cancer 118:6039–6045 PubMedCentralCrossRefPubMed Guller U, Zettl A, Worni M et al (2012) Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging? Cancer 118:6039–6045 PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Saha S, Bilchik A, Wiese D et al (2001) Ultrastaging of colorectal cancer by sentinel lymph node mapping technique—a multicenter trial. Ann Surg Oncol 8:94S–98SPubMed Saha S, Bilchik A, Wiese D et al (2001) Ultrastaging of colorectal cancer by sentinel lymph node mapping technique—a multicenter trial. Ann Surg Oncol 8:94S–98SPubMed
21.
Zurück zum Zitat van der Pas MH, Meijer S, Hoekstra OS et al (2011) Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol 12:540–550CrossRefPubMed van der Pas MH, Meijer S, Hoekstra OS et al (2011) Sentinel-lymph-node procedure in colon and rectal cancer: a systematic review and meta-analysis. Lancet Oncol 12:540–550CrossRefPubMed
22.
Zurück zum Zitat Viehl CT, Guller U, Cecini R et al (2012) Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol 19:1959–1965CrossRefPubMed Viehl CT, Guller U, Cecini R et al (2012) Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol 19:1959–1965CrossRefPubMed
23.
Zurück zum Zitat Morton DL, Hoon DS, Cochran AJ et al (2003) Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238:538–549PubMedCentralPubMed Morton DL, Hoon DS, Cochran AJ et al (2003) Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238:538–549PubMedCentralPubMed
25.
26.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C, Digestive System Tumours (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York, pp 100–105 Sobin LH, Gospodarowicz MK, Wittekind C, Digestive System Tumours (2009) TNM classification of malignant tumours, 7th edn. Wiley, New York, pp 100–105
27.
Zurück zum Zitat Nicastri DG, Doucette JT, Godfrey TE et al (2007) Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 9:563–571PubMedCentralCrossRefPubMed Nicastri DG, Doucette JT, Godfrey TE et al (2007) Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 9:563–571PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Rahbari NN, Bork U, Motschall E et al (2012) Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 30:60–70CrossRefPubMed Rahbari NN, Bork U, Motschall E et al (2012) Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol 30:60–70CrossRefPubMed
29.
Zurück zum Zitat Nissan A, Protic M, Bilchik AJ et al (2012) United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) Randomized Controlled Trial Comparing Targeted Nodal Assessment and Ultrastaging With Standard Pathological Evaluation for Colon Cancer. Ann Surg 256:412–427CrossRefPubMed Nissan A, Protic M, Bilchik AJ et al (2012) United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) Randomized Controlled Trial Comparing Targeted Nodal Assessment and Ultrastaging With Standard Pathological Evaluation for Colon Cancer. Ann Surg 256:412–427CrossRefPubMed
30.
Zurück zum Zitat Bilchik A, Nissan A, Wainberg Z et al (2010) Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg 252:467–474PubMedCentralPubMed Bilchik A, Nissan A, Wainberg Z et al (2010) Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg 252:467–474PubMedCentralPubMed
31.
Zurück zum Zitat Joseph NE, Sigurdson ER, Hanlon AL et al (2003) Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10:213–218CrossRefPubMed Joseph NE, Sigurdson ER, Hanlon AL et al (2003) Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10:213–218CrossRefPubMed
32.
Zurück zum Zitat Sobin LH, Greene FL (2001) TNM classification: clarification of number of regional lymph nodes for pN0. Cancer 92:452CrossRefPubMed Sobin LH, Greene FL (2001) TNM classification: clarification of number of regional lymph nodes for pN0. Cancer 92:452CrossRefPubMed
Metadaten
Titel
Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients
verfasst von
Benjamin Weixler
Rene Warschkow
Andreas Zettl
Hans-Martin Riehle
Ulrich Guller
Carsten T. Viehl
Markus Zuber
Publikationsdatum
01.10.2015
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 10/2015
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-015-3130-5

Weitere Artikel der Ausgabe 10/2015

World Journal of Surgery 10/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.